Cellanyx 20logo 20may 202017
Twitterlogo

Cellanyx

Commercializing a first-in-class machine learning-powered biopsy-on-a-chip platform for precision cancer testing and personalized therapies.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Boston, MA, USA
  • Currency USD
  • Founded January 2013
  • Employees 8
  • Incorporation Type LLC
  • Website cellanyx.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.